Becton, Dickinson and Company Share Price Wiener Boerse

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 12:21:10 07/06/2024 am IST 5-day change 1st Jan Change
220.2 EUR +3.79% Intraday chart for Becton, Dickinson and Company +1.63% -3.55%

Financials

Sales 2024 * 20.25B 18.59B 1,690B Sales 2025 * 21.43B 19.67B 1,788B Capitalization 68.29B 62.71B 5,700B
Net income 2024 * 2.09B 1.92B 175B Net income 2025 * 2.48B 2.28B 207B EV / Sales 2024 * 4.02 x
Net Debt 2024 * 13.13B 12.06B 1,096B Net Debt 2025 * 10.8B 9.91B 901B EV / Sales 2025 * 3.69 x
P/E ratio 2024 *
33.2 x
P/E ratio 2025 *
29.4 x
Employees 73,000
Yield 2024 *
1.59%
Yield 2025 *
1.63%
Free-Float 77.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.79%
1 week+1.63%
1 month-2.71%
3 months-2.21%
6 months-2.66%
Current year-3.55%
More quotes
1 week
209.70
Extreme 209.7
219.90
1 month
205.90
Extreme 205.9
221.90
Current year
205.90
Extreme 205.9
229.00
1 year
205.90
Extreme 205.9
261.00
3 years
195.50
Extreme 195.5
264.80
5 years
189.14
Extreme 189.14
264.80
10 years
189.14
Extreme 189.14
264.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/09/01
Director of Finance/CFO 52 06/21/06
Chief Tech/Sci/R&D Officer 48 01/19/01
Members of the board TitleAgeSince
Director/Board Member 73 24/02/24
Director/Board Member 73 29/13/29
Director/Board Member 69 26/10/26
More insiders
Date Price Change
31/24/31 212.2 +1.87%
05/24/05 218 -0.23%
04/24/04 218.5 +1.86%
03/24/03 214.5 +1.08%
31/24/31 212.2 +1.87%

End-of-day quote Wiener Boerse, May 31, 2024

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
236.3 USD
Average target price
278.7 USD
Spread / Average Target
+17.94%
Consensus